Glomerular volume and renal histology in obese and non-obese living kidney donors

被引:98
作者
Rea, D. J. [1 ]
Heimbach, J. K. [1 ]
Grande, J. P. [1 ]
Textor, S. C. [1 ]
Taler, S. J. [1 ]
Prieto, M. [1 ]
Larson, T. S. [1 ]
Cosio, F. G. [1 ]
Stegall, M. D. [1 ]
机构
[1] Mayo Clin, William J Von Liebig Transplant Ctr, Coll Med, Rochester, MN 55904 USA
关键词
kidney biopsy; kidney transplantation; kidney donation; obesity; microalbuminuria;
D O I
10.1038/sj.ki.5001799
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The link between obesity and renal disease is unclear, and there is no consensus as to whether obese individuals are at increased risk for kidney disease after living kidney donation if they otherwise meet acceptance criteria. We retrospectively studied time-zero (implantation) biopsies in 49 obese (body mass index (BMI) >= 30 kg/m(2)) and 41 non-obese (BMI < 30 kg/m(2)) renal donors that met acceptance criteria. We found that our obese donor population had higher systolic blood pressure (P < 0.001 vs non-obese) and higher absolute iothalamate clearance (P=0.001 vs non-obese) before donation. The obese donors had larger glomerular planar surface area compared to non-obese controls (P=0.017), and this parameter correlated with patient weight and urinary microalbumin excretion. Detailed examination of the biopsies revealed that although most histologic findings were similar between groups, the obese donors had more tubular dilation (P=0.01), but less tubular vacuolization (P=0.02) than the non-obese controls. There was also a trend toward more arterial hyalinosis in the obese patients than controls (P=0.08). From these data, our studies detected subtle differences in donor organs obtained from obese compared to non-obese individuals. Further studies should be carried out to quantify the long-term impact of these findings.
引用
收藏
页码:1636 / 1641
页数:6
相关论文
共 21 条
[1]   Baseline glomerular size as a predictor of function in human renal transplantation [J].
Abdi, R ;
Slakey, D ;
Kittur, D ;
Burdick, J ;
Racusen, L .
TRANSPLANTATION, 1998, 66 (03) :329-333
[2]   Overview: Obesity: What does it have to do with kidney disease? [J].
Abrass, CK .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (11) :2768-2772
[3]   Fibrous intimal thickening at implantation as a risk factor for the outcome of cadaveric renal allografts [J].
Bosmans, JL ;
Woestenburg, A ;
Ysebaert, DK ;
Chapelle, T ;
Helbert, MJ ;
Corthouts, R ;
Jürgens, A ;
Van Daele, A ;
Van Marck, EA ;
De Broe, ME ;
Verpooten, GA .
TRANSPLANTATION, 2000, 69 (11) :2388-2394
[4]   Kidney allograft fibrosis and atrophy early after living donor transplantation [J].
Cosio, FG ;
Grande, JP ;
Larson, TS ;
Gloor, JM ;
Velosa, JA ;
Textor, SC ;
Griffin, MD ;
Stegall, MD .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (05) :1130-1136
[5]   Reversal of lesions of diabetic nephropathy after pancreas transplantation [J].
Fioretto, P ;
Steffes, MW ;
Sutherland, DER ;
Goetz, FC ;
Mauer, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (02) :69-75
[6]   Long-term consequences of live kidney donation follow-up in 93% of living kidney donors in a single transplant center [J].
Gossmann, J ;
Wilhelm, A ;
Kachel, HG ;
Jordan, J ;
Sann, U ;
Geiger, H ;
Kramer, W ;
Scheuermann, EH .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (10) :2417-2424
[7]   Progression of renal disease: new insights into risk factors and pathomechanisms [J].
Gross, ML ;
Amann, K .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2004, 13 (03) :307-312
[8]   Obesity in living kidney donors: Clinical characteristics and outcomes in the era of laparoscopic donor nephrectomy [J].
Heimbach, JK ;
Taler, SJ ;
Prieto, M ;
Cosio, FG ;
Textor, SC ;
Kudva, YC ;
Chow, GK ;
Ishitani, MB ;
Larson, TS ;
Stegall, MD .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (05) :1057-1064
[9]   Obesity-related glomerulopathy: An emerging epidemic [J].
Kambham, N ;
Markowitz, GS ;
Valeri, AM ;
Lin, J ;
D'Agati, VD .
KIDNEY INTERNATIONAL, 2001, 59 (04) :1498-1509
[10]  
Kasiske BL, 1996, J AM SOC NEPHROL, V7, P2288